News Daily News IVUS, OCT Each Bring Something to the Table for PCI in Complex Lesions: Meta-analysis Caitlin E. Cox January 20, 2026
News Conference News AHA 2025 Prasugrel May Be Better Than Ticagrelor After PCI for Diabetes Patients With MVD Todd Neale November 13, 2025
News Conference News AHA 2025 Anticoagulation Alone Is Best in AF Patients a Year or More Out From PCI Todd Neale November 09, 2025
News Conference News TCT 2025 LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI L.A. McKeown October 27, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Conference News ESC 2025 Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD L.A. McKeown September 05, 2025
News Conference News ESC 2025 No Benefit to Routine CT Angiography After Left Main PCI: PULSE Michael O'Riordan August 31, 2025
News Conference News ESC 2025 Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF Michael O'Riordan August 30, 2025
News Daily News Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis L.A. McKeown August 12, 2025
News Daily News POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies L.A. McKeown July 15, 2025
News Daily News Trade-offs With Invasive Strategy in Older Patients With ACS: Meta-analysis Michael O'Riordan July 03, 2025
News Conference News EuroPCR 2025 Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS L.A. McKeown May 30, 2025
News Daily News The ‘Smoker’s Paradox’ Takes a New Hit From Long-term Analysis Yael L. Maxwell March 24, 2025
News Conference News CRT 2025 AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years L.A. McKeown March 10, 2025
News Daily News BMJ Investigation Revives Questions About PLATO, Ticagrelor Todd Neale December 20, 2024
News Daily News Potential Sex Differences Seen for FFR-Guided PCI vs CABG in FAME 3 Todd Neale December 09, 2024
News Conference News VIVA 2024 Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II L.A. McKeown November 06, 2024
News Conference News VIVA 2024 Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK L.A. McKeown November 05, 2024